Stage I Breast Cancer

7

Review clinical trials related to Stage I Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Researching the Effect of Exercise on Cancer

Researchers think that exercise may be able to prevent cancer from coming back by lowering ctDNA levels. The purpose of this study is to explore how aerobic exercise (exercise that stimulates and strengthens the heart and lungs and improves the body's use of oxygen) can reduce the level of ctDNA found in the blood. During the study, the highest level of exercise that is practical, is safe, and has positive effects on the body that may prevent the return of cancer (including a decrease in ctDNA levels) will be found. Each level of exercise tested will be a certain number of minutes each week. Once the best level of exercise is found, it will be tested further in a new group of participants. All participants in this study will have been previously treated for breast, prostate, or colorectal cancer.

Participants needed: 51
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: City of Hope Medical CenterUpdated: Aug 27, 2026Locations: 9
Eligibility criteria

Stage 3 or [+12]

Enrollment onto any other interventional investigational study except interventi... [+3]

Status: Recruiting

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to schedule and at the planned dose.

Participants needed: 270
Trial details
Age: 65+Biological sex: FemaleType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: Jul 17, 2026Locations: 4
Eligibility criteria

Women age >=65 [+7]

Following a therapeutic diet for co-morbid disease where the THRIVE-65 diet woul... [+6]

Status: Recruiting

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Participants needed: 1,670
Trial details
Phase: Phase 3Age: 50-70Biological sex: AllType: InterventionalSponsor: NRG OncologyUpdated: Apr 23, 2026Locations: 832
Eligibility criteria

• The patient or a legally authorized representative must provide study-specific... [+15]

• Definitive clinical or radiologic evidence of metastatic disease. [+24]

Status: Recruiting

A Study of Revaree Plus in People With Breast Cancer

The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.

Participants needed: 60
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Feb 6, 2026Locations: 7
Eligibility criteria

≥18 years of age at the time of signing informed consent. [+9]

Inability to provide informed consent [+4]

Status: Not yet recruiting

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

The purpose of this study is to develop and test a new intervention to reduce depressive symptoms in post-treatment cancer participants.

Participants needed: 76
Trial details
Biological sex: AllType: InterventionalSponsor: Case Comprehensive Cancer CenterUpdated: Jan 23, 2026Locations: 1
Eligibility criteria

Self-reported mild to moderately-severe symptoms of depression (score 5-19 on PH... [+5]

Self-reported minimal and severe depressive symptoms (<4 and > 20 on PHQ-9). [+7]

Status: Recruiting

A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

The goal of this clinical trial is to learn if tattoos applied with Magic Ink is as safe as commercially available standard tattoo ink for the purpose of radiation in women with breast cancer undergoing radiation treatment. The main questions are: * Is the Magic Ink as safe as standard tattoo ink * Does Magic Ink continue to function and remain visible for radiation therapists during the treatment Participants will be consented and given a skin assessment. Once enrolled participants will be administered the Magic Ink tattoo instead of the standard tattoo ink in preparation for their radiation treatment. Participants will also complete a survey regarding body image. Skin assessment will occur again after the first week of radiation and at 3 months later. Throughout the radiation therapy the medical physicist will complete surveys about ease of set-up of the equipment.

Participants needed: 30
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Barbara Ann Karmanos Cancer InstituteUpdated: Sep 18, 2025Locations: 1
Eligibility criteria

Participant must have histologically or cytologically confirmed stage 0 ductal c... [+10]

Participants who have received prior radiation treatment to the affected breast. [+4]

Status: Recruiting

Comparison Between Prepectoral and Subpectoral Breast Reconstruction

There are controversies about breast implant-based reconstruction techniques. Our center pioneered single-port insufflation endoscopic nipple-sparing mastectomy (SIE-NSM) combined with stage I prosthesis reconstruction. The study's primary objective is to compare single-port endoscopic NSM combined with pre-pectoral breast reconstruction to the subpectoral breast reconstruction group regarding breast satisfaction. This study is an ambispective cohort study. The study will be conducted at Beijing Friendship Hospital, affiliated with Capital Medical University. Patients will be enrolled retrospectively from January 2014 to March 2022 by reviewing the medical records and recruited prospectively from March 2022 to March 2025. The two cohorts are the pre-pectoral breast reconstruction cohort and the subpectoral breast reconstruction cohort, both following single-port insufflation endoscopic nipple-sparing mastectomy. The primary outcome of this study is postoperative breast satisfaction, which the BREAST-Q score will measure. The different variables will be compared using the Χ2 test for categorical variables and the Mann-Whitney test for continuous variables.

Participants needed: 88
Trial details
Age: 18-70Biological sex: FemaleType: ObservationalSponsor: Beijing Friendship HospitalUpdated: Apr 27, 2023Locations: 1
Eligibility criteria

Female patients with preoperative pathologically confirmed early-stage invasive... [+7]

patients having serious medical diseases, including unstable angina pectoris, my... [+4]